The Surgery Center at 900 North Michigan Avenue, LLC v. American Physicians Assurance Corporation, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJune 5, 2018
Docket1:15-cv-04336
StatusUnknown

This text of The Surgery Center at 900 North Michigan Avenue, LLC v. American Physicians Assurance Corporation, Inc. (The Surgery Center at 900 North Michigan Avenue, LLC v. American Physicians Assurance Corporation, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Surgery Center at 900 North Michigan Avenue, LLC v. American Physicians Assurance Corporation, Inc., (N.D. Ill. 2018).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS

THE SURGERY CENTER at 900 ) NORTH MICHIGAN AVENUE, LLC, ) ) Plaintiff, ) ) Case No. 15-CV-4336 v. ) ) Judge Sharon Johnson Coleman AMERICAN PHYSICIANS ASSURANCE ) CORPORATION, INC., and AMERICAN ) PHYSICIANS CAPITAL, INC., ) ) Defendants. )

MEMORANDUM OPINION AND ORDER Plaintiff, The Surgery Center at 900 North Michigan Avenue, LLC (“TSC”), filed suit against Defendants, American Physicians Assurance Corporation, Inc., and American Physicians Capital, Inc. (collectively “APAC”) alleging that APAC acted in bad faith by not settling the underlying law suit in the Circuit Court of Cook County, IL—Tate v. The Surgery Center at 900 N. Michigan Ave, LLC, Case No. 03-L-6090. TSC also alleges that APAC breached its fiduciary duties and institutional liability to the Surgery Center under their insurance contract, and that APAC had a tacit agreement with the defense counsel to not fully advise the Surgery Center in the underlying suit. APAC now moves for summary judgment on all three claims. For the foregoing reasons, APAC’s Motion for Summary Judgement [218] is denied. APAC’s Alternative Motion for Summary Judgment [220] addresses the same matters and requires the same consideration of this Court as the aforementioned motion. It is also denied. Background The following facts are undisputed unless noted. On November 26, 2002, Dr. Harrith Hasson (“Dr. Hasson”) performed a laparoscopic surgery on Gwendolyn Tate (“Tate”) at the TSC facility. Four days later, Tate was admitted into the hospital with complications that left her quadriplegic. Tate sued both Dr. Hasson and TSC in the Circuit Court of Cook County State Court (“Tate Case”) on May 21, 2003. APAC was the professional liability carrier provider for TSC. TSC’s insurance policy limit was set at $1 million. APAC hired the law firm, Lowis & Gellen to defend TSC in accordance with APAC’s Defense Attorney Instructions. TSC contends that in 2005, while the Tate Case was pending, APAC’s new vice president of claims implemented a company-wide policy, the “concrete

plan,” that would employ a more aggressive defense strategy. This included refusing to negotiate settlement and targeting certain high exposure claims for trial regardless of the risk imposed. While APAC agrees that the vice-president was asked by policyholders to adopt more aggressive tactics in defending and settling claims, APAC disputes the existence of an official plan that refused to negotiate settlement or pushed high exposure cases to trial. TSC states that the “concrete plan” was codified in a “best practices” newsletter and promoted to the policyholders and defense counsel; however, APAC characterizes information as mere marketing material with no manipulative intent. TSC also contends that the “concrete plan” involved reducing the amount of defense firms APAC used to those who would abide by the expectations of the plan. APAC attributes the reduced number of firms to its effort to improve the consistency and quality of the attorneys hired to represent policyholders. Lowis & Gellen was on the approved list of firms, and was expected to adhere to APAC’s Defense Attorney Guidelines per the contract. Parties dispute whether those guidelines included the “concrete plan.” From 2003 to 2010, Lowis & Gellen earned over $10

million from cases referred by APAC. Both Jennifer Lowis (“Lowis”) and Mark Smith (“Smith”) of the Lowis & Gellen represented TSC in the Tate Case. Guita Griffiths (“Griffiths”) was the president of TSC. She was APAC and the defense counsel’s point of contact for the Tate litigation. She is also a lawyer. APAC alleges that upon receiving Tate’s complaint, it warned Griffiths about the risk of an adverse verdict against TSC and TSC’s right to retain its own personal counsel to advise TSC on settling the case. TSC denies that APAC ever advised Griffiths on the aforementioned. On November 8, 2004, APAC raised the Reserve, money put aside in the event that there is a verdict that has to be paid, to $560,000. The Reserve amount, which represents the value of the Tate Case, was calculated by multiplying the Full Liability Value ($8 million) by the chance of losing (70%) and the insured’s percentage share (10%). APAC maintains that it does not use the

methodology for determining the Reserve amount as a means of assessing the likelihood of success at trial. TSC disputes this fact. APAC labeled the Tate Case as “high exposure” because it believed the damages from an adverse verdict on the claim could exceed TSC’s policy limit. In July 2007, Tate’s counsel offered to settle the case for the $1 million policy limit. The parties dispute whether this offer was discussed with TSC before proceeding, but they agree that APAC rejected this settlement demand. On August 3, 2007, Dr. Hassan settled with Tate for $1 million. Lowis subsequently moved to reconsider TSC’s summary judgment motion, and it was granted. In December 2009, the Illinois Court of Appeals partially reversed the grant of summary judgment, finding that there was a triable issue with regard to whether TSC, through its nursing staff, breached the appropriate standard of care and whether that breach was a proximate cause of Tate’s injury. The Tate Case was remanded for trial proceedings. In February 2010, APAC raised the Tate Case’s Reserve to $1 million. TSC maintains that this number reflected a determination that TSC had at least a 50% chance of losing at trial. APAC again denies that the Reserve

Evaluation Forms are used to assess the likelihood of success at trial, but also does not explain what factors go into the calculations. APAC concurs that it did not inform TSC about increasing the Reserve, but it still maintains that 50% loss evaluation used in determining the Reserve did not impact the manner in which they assessed TSC’s success since APAC always believed TSC’s chances of losing were no greater than 25%. That same month, APAC wrote TSC to advise them that they believed the case was defensible and they would likely prevail despite the result of the appeal. On April 5, 2010, Smith stated that he believed TSC would have a 90% chance of winning at trial. TSC disputes the veracity of this figure and believes the statement was influenced by the “concrete plan,” not an honest assessment of the likelihood for success. On May 11, 2010, before the trial, Tate sent APAC a settlement demand for the $1 million policy limit. Six days later, APAC

rejected Tate’s policy limit demand and wrote to advise TSC that they would not be entering into any settlement negotiations since the case was still defensible and that TSC would likely prevail at trial. APAC also asserts that it repeatedly advised TSC of the risk of a verdict in excess of the policy limits and of TSC’s right to obtain personal counsel. TSC disputes that APAC discussed this settlement request, the risks of settlement versus trial, obtaining personal counsel, or APAC’s decision not to negotiate with TSC with it before trial. TSC also asserts that, at the time of the second settlement offer, APAC was aware of several damaging facts, including that Tate would testify as to not receiving proper discharge instructions personally in violation of TSC’s own rules and regulations, and that an expert would testify that the failure to properly discharge was a proximate cause of her injuries. APAC does not dispute these facts, but instead states their irrelevance. After the trial concluded, the jury returned a verdict of $5.12 million in favor of Tate. TSC contends that APAC and defense counsel had a meeting about the adverse verdict, but they did not

include TSC or Griffiths. Before the resolution of TSC’s post-trial motions, and without informing APAC beforehand, Griffiths’ personal counsel, who she retained after the verdict, contacted Tate’s attorney about a settlement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Central Illinois Public Service Co. v. Agricultural Insurance
880 N.E.2d 1172 (Appellate Court of Illinois, 2008)
Haddick Ex Rel. Griffith v. Valor Insurance
763 N.E.2d 299 (Illinois Supreme Court, 2001)
Sikiru Adeyeye v. Heartland Sweeteners, LLC
721 F.3d 444 (Seventh Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
The Surgery Center at 900 North Michigan Avenue, LLC v. American Physicians Assurance Corporation, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-surgery-center-at-900-north-michigan-avenue-llc-v-american-physicians-ilnd-2018.